Literature DB >> 28523146

Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise.

Houda Bahig1, Hanbo Chen2, Alexander V Louie2.   

Abstract

Entities:  

Year:  2017        PMID： 28523146      PMCID： PMC5418272          DOI： 10.21037/jtd.2017.03.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.

Authors:  Varun Puri; Traves D Crabtree; Steven Kymes; Martin Gregory; Jennifer Bell; Jeffrey D Bradley; Clifford Robinson; G Alexander Patterson; Daniel Kreisel; Alexander S Krupnick; Bryan F Meyers
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12-09       Impact factor: 5.209

2.  Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.

Authors:  Shervin M Shirvani; Jing Jiang; Joe Y Chang; James W Welsh; Daniel R Gomez; Stephen Swisher; Thomas A Buchholz; Benjamin D Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-11       Impact factor: 7.038

3.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

4.  Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.

Authors:  David Palma; Otto Visser; Frank J Lagerwaard; Jose Belderbos; Ben Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2011-07-19       Impact factor: 6.280

5.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Authors:  Shervin M Shirvani; Jing Jiang; Joe Y Chang; James Welsh; Anna Likhacheva; Thomas A Buchholz; Stephen G Swisher; Benjamin D Smith
Journal:  JAMA Surg       Date:  2014-12       Impact factor: 14.766

6.  Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.

Authors:  Varun Puri; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Morgensztern; Graham A Colditz; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers; Aalok Patel; Clifford G Robinson
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

7.  Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.

Authors:  John Varlotto; Achilles Fakiris; John Flickinger; Laura Medford-Davis; Adam Liss; Julia Shelkey; Chandra Belani; Jill DeLuca; Abram Recht; Neelabh Maheshwari; Robert Barriger; Nengliang Yao; Malcolm DeCamp
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

Review 8.  Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review.

Authors:  Hermine Poghosyan; Lisa Kennedy Sheldon; Suzanne G Leveille; Mary E Cooley
Journal:  Lung Cancer       Date:  2013-04-04       Impact factor: 5.705

9.  Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.

Authors:  Alexander V Louie; Erik van Werkhoven; Hanbo Chen; Egbert F Smit; Marinus A Paul; Joachim Widder; Harry J M Groen; Ben E E M van den Borne; Katrien De Jaeger; Ben J Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2015-10       Impact factor: 6.280

Review 10.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534
View more
  2 in total

1.  Shared decision making in the treatment of stage I non small cell lung cancer-a choice which should equally involve both sides.

Authors:  Aurel Ottlakan; Jozsef Furak; Gaetano Rocco
Journal:  Ann Transl Med       Date:  2017-09

2.  Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancer.

Authors:  Dan Yang; Jianing Cui; Jun Zhao; Jing You; Rong Yu; Huiming Yu; Leilei Jiang; Dongming Li; Bo Xu; Anhui Shi
Journal:  Thorac Cancer       Date:  2020-02-03       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.